These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3530598)

  • 1. Immunological monitoring of bone marrow transplantation.
    Voltarelli JC; Stites DP
    Diagn Immunol; 1986; 4(4):171-93. PubMed ID: 3530598
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation in severe combined immunodeficiency: potential and current limitations.
    Friedrich W; Knobloch C; Greher J; Hartmann W; Peter HH; Goldmann SF; Kleihauer E
    Immunodeficiency; 1993; 4(1-4):315-22. PubMed ID: 8167725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic monitoring in allogeneic bone marrow transplantation].
    Serova LD; Voĭtenko LM; Mishina LV; Shabalin VN
    Vestn Akad Med Nauk SSSR; 1981; (10):57-62. PubMed ID: 7032118
    [No Abstract]   [Full Text] [Related]  

  • 4. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients.
    Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients.
    Klaesson S; Ringdén O; Markling L; Tammik L
    Transplant Proc; 1995 Dec; 27(6):3536-7. PubMed ID: 8540089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunology of bone marrow grafts].
    Dreyfus F
    Ann Med Interne (Paris); 1986; 137(8):617-20. PubMed ID: 3551717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of monoclonal antibodies in human bone marrow transplantation.
    Neudorf SM; Filipovich AH; Kersey JH
    Prog Clin Biol Res; 1984; 149():367-77. PubMed ID: 6377327
    [No Abstract]   [Full Text] [Related]  

  • 10. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell depletion of human bone marrow for allogeneic marrow transplantation.
    Farrelly H; Cooley M; O'Flaherty E; Biggs J; Atkinson K
    Transplant Proc; 1987 Apr; 19(2):2855-7. PubMed ID: 3551227
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
    Maraninchi D
    Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
    Lamb LS; Gee AP; Henslee-Downey PJ; Geier SS; Hazlett L; Pati AR; Godder K; Abhyankar SA; Turner MW; Lee C; Harris WG; Parrish RS
    Bone Marrow Transplant; 1998 Mar; 21(5):461-71. PubMed ID: 9535038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
    de Vries E; van Tol MJ; van den Bergh RL; Waaijer JL; ten Dam MM; Hermans J; Vossen JM
    Bone Marrow Transplant; 2000 Feb; 25(3):267-75. PubMed ID: 10673698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.